Evelyn Spiller, BS

Evelyn Spiller holds a BS in Public Health and Infectious Disease and is expected to complete her MSc in Epidemiology later this year. She has coordinated clinical trials since 2022 and has specialized in movement disorder research since 2023, with experience in Parkinson’s disease, essential tremor, cervical dystonia, and multiple system atrophy. She currently oversees regulatory activities for the Parkinson’s and Movement Disorders team, independently coordinates the PASADENA and TOPAS-MSA trials, and jointly coordinates the ex-PDite-2 stem cell trial. She is passionate about clinical research and innovation and considers it a privilege to help advance medical knowledge and expand therapeutic options for patients.